Fri, Aug 22, 2014, 4:17 AM EDT - U.S. Markets open in 5 hrs 13 mins

Recent

% | $
Quotes you view appear here for quick access.

Frisch's Restaurants, Inc. Message Board

ranting1704 4 posts  |  Last Activity: Jul 28, 2014 10:23 AM Member since: Apr 26, 2004
  • Reply to

    Who was buying ACAD at $2

    by iknightu Jul 24, 2014 8:53 PM
    ranting1704 ranting1704 Jul 28, 2014 10:23 AM Flag

    The current shares that I'm holding were purchased at $0.97, $1.73, $1.50, and $1.59 - mostly 2012, but some in 2010. Feeling lucky. I sold some prematurely.

  • Reply to

    do i have the chance to buy @4 like big guys?

    by biotrader888 Jun 6, 2014 9:17 AM
    ranting1704 ranting1704 Jun 6, 2014 9:25 AM Flag

    It is going to be very interesting to see what happens over the next couple of days. Someone on this board speculated that the shares were already sold. If so, I don't suspect the the price will drop to $4.00. Like RConre, I hope NVAX puts out a press release explaining their need to raise more money. They better have a good reason that pays off for shareholders quickly.

  • Reply to

    A little professional fear mongering

    by trippinginthefall Jun 3, 2014 9:37 PM
    ranting1704 ranting1704 Jun 4, 2014 9:55 AM Flag

    Trip, Do you still live in CH? Maybe one of these days we'll get to have that drink at the NST or The C.

  • http://news.nationalgeographic.com/news/2014/05/140523-mers-vaccine-camels-virus-flu-saudi-pandemic-science/

    "Although the science of making a vaccine against MERS is feasible—unlike, say, HIV, which has stymied researchers for decades—neither the market economy nor the vaccine development process is likely to support it, experts say."

    "Several academic researchers agreed that it doesn't make sense to spend time and money developing a MERS vaccine right now. Despite its recent spread, the disease, first identified in 2012, has been relatively contained so far and doesn't seem to be as contagious as SARS. Also, like any medication, a vaccine would certainly have side effects."

    "Developing a vaccine for camels would be cheaper, faster, and easier than developing one for people, he said, without the same level of safety concerns. He thinks it's possible to get a vaccine into camels even before October's hajj pilgrimage."

    Sentiment: Buy

FRS
25.00010.0000(0.00%)Aug 20 4:00 PMEDT

Trending Tickers

i
Trending Tickers features significant U.S. stocks showing the most dramatic increase in user interest in Yahoo Finance in the previous hour over historic norms. The list is limited to those equities which trade at least 100,000 shares on an average day and have a market cap of more than $300 million.